Comparison of the clinical effect of the adhesive strategies of universal adhesives in the treatment of non-carious cervical lesions: systematic review and meta-analysis

Objective: to compare, through a systematic review and a meta-analysis, the clinical effect of the adhesive strategies of universal adhesives (UA) in the treatment of non-carious cervical lesions (NCCLs). material and method: a search of the literature was carried out up to january 2018, in the biomedical databases: Pubmed, Embase, Scielo, Science Direct, SIGLE, LILACS, BBO, Google Scholar and the Central Register of Cochrane Clinical Trials. the selection criteria of the studies were as: randomized clinical trials, with a maximum age of 5 years and which report the clinical effects (marginal adaptation, discoloration or marginal staining, presence of secondary caries, postoperative sensitivity, retention and fractures) of the UA in the treatment of NCCLs. the risk of study bias was analyzed through the Cochrane Handbook of systematic reviews of interventions. results: the search strategy resulted in eight articles that reported no difference in marginal adaptation, discoloration or marginal staining, presence of secondary caries and postoperative sensitivity among the adhesive strategies of the UA; however they reported a difference between the retention and the presence of fractures, with the conventional adhesive strategy resulting in a better clinical effect. conclusion: the reviewed literature suggests that the conventional adhesive strategy of UAs results in greater retention and absence of fractures in the treatment of NCCLs.

Comparing the periodontal clinical effect between conventional and self-ligating brackets: systematic review and meta-analysis

Introduction: orthodontists constantly seek to reduce the duration of their provided treatments and the patient's time in the office. for this reason, different bracket systems are currently used in orthodontics; an example is self-ligating brackets (SLB) which are believed to offer advantages over conventional brackets (CB). objective: to evaluate and compare the clinical periodontal effect of CB and SLB through a systematic review and a meta-analysis. material and method: a search of the literature was carried out until December 2017, in the biomedical databases: PubMed, Embase, SciELO, ScienceDirect, SIGLE, LILACS, BBO, Google Scholar and the Cochrane Central Register of Controlled Trials. the selection criteria of the studies were defined as such: randomized clinical trials, up to 5 years old and that report the clinical effects (probing depth, bleeding on probing, gingival index and plaque index) from the use of CB and SLB. the risk of study bias was analyzed through the Cochrane Handbook of systematic reviews of interventions. results: the search strategy resulted in 12 articles, eight of which reported no difference in the reduction in probing depth, bleeding on probing, gingival index and plaque index (p>0.05) between CB and SLB. conclusion: the literature reviewed suggests that there are no differences in the periodontal clinical effect among patients who received orthodontic treatment with CB or SLB.

Association between periodontal disease and polycystic ovary syndrome: a scoping review

Background: polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in women. it is believed that sex hormones play a role in the maintenance of bone mass and directly or indirectly influence several cell types, including periodontal cells. objective: to evaluate the association between periodontal disease and PCOS according to the evidence reported in the last decade. material and method: a search was made in the biomedical databases: Pubmed, Embase, Scopus, SciELO, Science Direct and SIGLE for the 2007-2017 period. selection criteria: prospective and retrospective studies reporting the relationship between periodontal disease and PCOS. the methodological quality of the studies was analyzed using the critical appraisal skills program scale. results: 10 articles were found: 1 clinical trial and 9 case-control studies. the number of patients ranged from 48 to 196, mean age between 23.3 and 28.1 years, age range between 15 and 45 years. studies were conducted in Turkey, India and Iran. all the studies presented good methodological quality and a positive association between PCOS and periodontal disease. conclusion: PCOS shows a positive and significant association with the clinical and molecular parameters of periodontal diseases.

Clinical effect of platelet rich fibrin in the treatment of periodontal intrabony defects. systematic review and meta-analysis

Background: There is currently no gold standard biomaterial for the treatment of periodontal intrabony defects (PIDs). One of the current options is the use of platelet-rich fibrin (PRF). Objective: To determine the clinical effect of PRF in the treatment of PID through a systematic review and meta-analysis. Materials and Methods: A literature search was conducted up to February 2017 in the following biomedical databases: Pubmed, Embase, Scielo, Science Direct, SIGLE, LILACS and in the Cochrane Central Register of Clinical Trials. The selection criteria included: randomized clinical trials published in the last 5 years, reporting clinical effects (probing depth, clinical insertion level or gingival recession), with a follow-up time equal to or greater than 6 months, and sample size larger than or equal to 10 patients reporting the use of PRF as a treatment for PID. The methodological quality of the studies was analyzed using the Cochrane Handbook of Systematic Reviews of Interventions as a reference. Results: The search strategy yielded 20 articles. A reduction in probing depth and an increase in clinical insertion level or a reduction in gingival recession is reported, when using PRF alone or in combination with another biomaterial or substance that stimulates tissue regeneration. Conclusion: The literature suggests that the use of PRF in the treatment of PIDs has a beneficial clinical effect when compared to control treatments.

Clinical effect of platelet rich plasma in the treatment of periodontal intrabony defects. systematic review and meta-analysis

Introduction: One of the consequences of periodontitis is periodontal intrabony defects (PID). Various biomaterials have been used for its treatment, but there is still no biomaterial considered as the gold standard. Current research is focused on the use of platelet-rich plasma (PRP) for the treatment of PID. Objective: To determine the clinical effect of PRP in the treatment of PID through a systematic review with meta-analysis. Materials and Methods: A literature search was conducted until February 2017 in the biomedical databases: Pubmed, Embase, Scielo, Science Direct, SIGLE, LILACS, IBECS, and the Cochrane Central Register of Clinical Trials. The criteria for the selection of the studies, which were randomized clinical trials, were the following: articles or papers published in the last 5 years, reporting clinical effects, with a follow-up time equal to or greater than 6 months, and a sample size equal to or greater than 10 patients reporting the use of PRP as a treatment for PID. The methodological quality of the studies was analyzed using the Cochrane Handbook of Systematic Reviews of Interventions as a reference. Results: The search strategy yielded nine articles reporting a reduction in probing depth and gingival recession, and an increase in clinical insertion level when using PRP alone or in combination with another biomaterial. Conclusion: The reviewed literature suggests that the use of PRP in the treatment of PID has a positive clinical effect.

Comparative performance of the protocol of plasma rich in growth factors - universal 1 (PRGF-U1) for obtaining platelet rich plasma

Objective: to compare the platelet concentration obtained after application of the protocol of plasma rich in growth factors - universal 1 (PRGF-U1) and the protocol of Anitua and Andia (PRP-A) for obtaining platelet rich plasma. Material and Method: A descriptive, cross-sectional and comparative study was carried out with a simple random probabilistic sample consisting of 16 patients who attended the Periodontics service of the Unit of Second Specialization in Stomatology of the National University of Trujillo. Five blood samples were obtained from each patient, after applying a health questionnaire to rule out any disease or drug consumption, in order to obtain the baseline platelet concentration and that obtained after PRGF-U1 and PRP-A. To compare the platelet concentrations of the two protocols, Student’s t-test was used considering a significance level of p<0.05. RESULTS: The baseline platelet concentration was 371,250 +/- 68,203 platelets/ μL, for PRGF-U1 it was 747,875 +/- 121,645 platelets/μL and for PRP-A it was 595,000 +/- 129,202 platelets/ML. A statistically significant difference (p<0.001) was found between both protocols. Conclusion: The PRGF-U1 protocol yielded a higher platelet concentration compared to the Anitua and Andia protocol.

Eagle syndrome: a narrative review / Síndrome de Eagle: una revisión narrativa

Abstract: painful disorders in the maxillofacial region are common in dental practice. Most of these conditions are not properly diagnosed because of inadequate knowledge of craniofacial and cervico-pharyngeal syndromes such as Eagle Syndrome. The aim of this review is to describe the general aspects, diagnosis and treatment of Eagle syndrome. Eagle syndrome or stylohyoid syndrome was first described by Watt W. Eagle in 1937. It was defined as orofacial pain related to the elongation of the styloid process and ligament stylohyoid calcification. The condition is accompanied by symptoms such as dysphonia, dysphagia, sore throat, glossitis, earache, tonsillitis, facial pain, headache, pain in the temporomandibular joint and inability to perform lateral movements of the neck. Diagnosis and treatment of Eagle syndrome based on symptoms and radiographic examination of the patient will determine the need for surgical or nonsurgical treatment. Eagle syndrome is a complex disorder demanding a thorough knowledge of its signs and symptoms to make a correct diagnosis and provide an appropriate subsequent treatment. Disseminating information about this syndrome among medical-dental professionals is essential to provide adequate dental care to patients.

Resumen: en la práctica odontológica, es frecuente encontrar alteraciones con sintomatología dolorosa en la región maxilofacial, las cuales no son apropiadamente diagnosticadas, a causa del desconocimiento de síndromes craneofaciales y cervicofaríngeos, como el Síndrome de Eagle. El objetivo de esta revisión es describir los aspectos generales, diagnóstico y tratamiento del Síndrome de Eagle. El Síndrome de Eagle o estilalgia es la entidad nosológica, descrita por Watt W. Eagle en 1937, definida como aquel dolor orofacial relacionado con la elongación de la apófisis estiloides y calcificación del ligamento estilohioideo; el cual está acompañado de síntomas como: disfonía, disfagia, dolor faríngeo, glositis, otalgia, tonsilitis, dolor facial, cefalea, odinofagia, dolor en la articulación temporomandibular e imposibilidad de realizar movimientos laterales del cuello. El diagnóstico y tratamiento del Síndrome de Eagle está basado en la sintomatología y el examen radiográfico del paciente, lo cual determinará el tratamiento quirúrgico o no quirúrgico. El Síndrome de Eagle es una patología compleja que requiere un conocimiento amplio de sus signos y síntomas, para establecer un correcto diagnóstico y posteriormente un adecuado tratamiento. Para ello, es necesario difundir la información sobre este síndrome entre los profesionales médico-odontológico y así brindar una atención adecuada a cada uno de los pacientes.

Dental implant survival rate in well controlled diabetic patients: a systematic review / Tasa de supervivencia de implantes dentales en pacientes diabéticos controlados: una revisión sistemática

Abstract: Background: dental implants have now become one of the most popular options for replacing a missing tooth. On the other hand, diabetes mellitus is a systemic disease that affects a large part of the population and is generally considered an absolute or relative contraindication to implant therapy. Aim: To determine the survival rate of dental implants in controlled diabetic patients through a systematic review. Material and methods: A systematic search in Pubmed, SciELO and RedALyC databases was performed. The selection criteria were: studies published in the last 10 years, with at least 20 controlled diabetic patients, reporting survival rate and number of implants placed, with follow-up periods equal to or longer than 1 year, including a control group of healthy patients. Methodological quality was analyzed with the follwing scales: Jadad and Downs & Black’s CMQ. Results: Three articles with a follow-up period between 1 and 12 years were analyzed. The overall survival rate of dental implants in diabetic controlled patients was 97.43 percent. Conclusion: The reviewed literature suggests that survival rate of dental implants in well-controlled diabetic patients is similar to non diabetic patients.

Resumen: Antecedentes: los implantes dentales se han convertido actualmente en una de las opciones más populares para sustituir un diente perdido. Por otro lado, la diabetes mellitus es una enfermedad sistémica que afecta a gran parte de la población y es considerada generalmente una contraindicación absoluta o relativa en la terapia con implantes. Objetivo: Determinar mediante una revisión sistemática la tasa de supervivencia de implantes dentales en pacientes diabéticos controlados. Materiales y métodos: Búsqueda sistemática en las bases de datos biomédicas Pubmed, SciELO y RedALyC. Los criterios de selección fueron: estudios publicados en los últimos 10 años, con al menos 20 pacientes diabéticos controlados, que reporten tasa de supervivencia y número de implantes colocados, con un seguimiento igual o superior a 1 año, con un grupo control de pacientes sanos. Se analizó la calidad metodológica de los estudios con las escalas Jadad y CMQ de Downs y Black. Resultados: Se analizaron tres artículos con un seguimiento de entre 1 y 12 años. La tasa de supervivencia global de los implantes dentales en los pacientes diabéticos controlados fue de un 97.43 por ciento. Conclusión: La literatura revisada sugiere que la supervivencia de los implantes dentales en pacientes diabéticos bien controlados es similar a pacientes no diabéticos.